Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5585141 | 1.00 | AR (0.98) | ARHDAC1 | |
| SCHEMBL5585094 | 1.00 | AR (0.98) | ARHDAC1 | |
| SCHEMBL5585121 | 1.00 | AR (0.98) | ARHDAC1 | |
| SCHEMBL5585067 | 1.00 | AR (0.98) | ARHDAC1 | |
| SCHEMBL5584935 | 0.99 | AR (1.00) | ARHDAC1 | |
| SCHEMBL5585057 | 0.96 | AR (1.00) | ARHDAC1 | |
| SCHEMBL5585303 | 0.93 | AR (1.00) | ARHDAC1 | |
| SCHEMBL5585175 | 0.90 | AR (0.93) | ARHDAC1 | |
| SCHEMBL5585176 | 0.90 | AR (0.93) | ARHDAC1 | |
| SCHEMBL5585301 | 0.90 | AR (0.93) | ARHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7271188-B2 | Imidazolidine derivatives | CHUGAI SEIKAYU KABUSHIKI KAISHA (JP) | 2007-09-18 | — | — | US | claimed |
| US-20060135583-A1 | Imidazolidine derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-06-22 | — | — | US | claimed |
| EP-1634874-A1 | IMIDAZOLIDINE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-03-15 | — | — | EP | claimed |
| US-7271188-B2 | Imidazolidine derivatives | CHUGAI SEIKAYU KABUSHIKI KAISHA (JP) | 2007-09-18 | — | — | US | disclosed |
| US-20060135583-A1 | Imidazolidine derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-06-22 | — | — | US | disclosed |
| EP-1634874-A1 | IMIDAZOLIDINE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135583-A1 | Imidazolidine derivatives | CYP3A5, CYP2C19, CYP3A7 | AR 2094/4885HDAC1 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.